Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection
Coronavirus disease 2019 (COVID-19) continuously progresses despite the application of a variety of vaccines. Therefore, it is still imperative to find effective ways for treating COVID-19. Recent studies indicate that NRP1, an important receptor of the natural peptide tuftsin (released from IgG), f...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2022-03-01
|
| Sarja: | Frontiers in Molecular Biosciences |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.859162/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|